An ideal approach should be minimally invasive, analyzing the membrane in a biologically relevant, free-solution environment.
Minimally, 150 nuclei were analyzed in duplicate per probe per cell line.
In the VLN, hepatic capacity in vivo is quantified by administering a standardized cocktail of marketed drugs to probe the activity of specific drug transporters or drug-metabolizing enzymes, and pharmacokinetic absorption, distribution, metabolism, and excretion processes are analyzed with minimally invasive procedures.
For the minimally invasive process that is analyzed here, no SOP exists.
As an alternative, CTCs can be repetitively sampled and analyzed in a minimally invasive manner, thus allowing real-time monitoring of the evolution of tumor driver mutations.
The ideal biological marker(s) for cancer risk assessment and early detection must have high sensitivity and specificity, be found in a biosample obtained using minimally invasive procedures, and be analyzed using a high-throughput, cost-effective assay.
Clinical meaningfulness was analyzed by estimating the minimally clinical important difference (MCID) under different assumptions of nail clearing and new nail growth.
Liquid biopsies including circulating tumor cells (CTCs) and cell-free DNA (cfDNA) have enabled minimally invasive characterization of many cancers, but are rarely analyzed together.
To arrive at this insight, we set up a rather generic pathway model and analyzed it in a fashion that is only minimally affected by the choice of particular parameter values.
Changes in pulse pressure variation, central venous pressure, median arterial pressure, and cardiac index were analyzed every hour over intermittent hemodynamics using a minimally hemodynamic monitoring device (LIDCO plus) in 28 mechanically ventilated patients.
